Type 2 Diabetes Whole Blood
Fresh whole blood from IRB-consented donors with confirmed type 2 diabetes. Suitable for HbA1c and glycaemic biomarker profiling, insulin resistance research, whole-blood transcriptomics, and genomic DNA extraction. Available stratified by glycaemic control, treatment regimen, and complication status, with matched healthy controls.
Type 2 Diabetes Whole Blood for Metabolic Disease Research
Type 2 Diabetes Whole Blood is collected from IRB-consented donors with a clinically confirmed type 2 diabetes diagnosis and shipped same-day so that cells, nucleic acids and plasma analytes are all recovered from a single intact specimen.
Type 2 Diabetes Metabolic Biology and Why Whole Blood
Type 2 diabetes is a metabolic disorder driven by peripheral insulin resistance together with progressive beta-cell secretory failure, resulting in chronic hyperglycaemia. It is not an autoimmune disease; islet autoantibodies are a feature of type 1 diabetes, not type 2.
- Insulin resistance in muscle, liver and adipose tissue is the core defect, compounded over time by declining beta-cell compensation
- Chronic low-grade metabolic inflammation, sometimes described as metaflammation, links adiposity to insulin resistance and is reflected in circulating cytokines and adipokines
- Sustained hyperglycaemia drives non-enzymatic glycation of haemoglobin, making HbA1c a red-cell-dependent measurement that requires intact whole blood
- Whole blood is the correct matrix for HbA1c, point-of-care glucose systems, and any assay that depends on erythrocytes being present
- Whole blood also supports PAXgene-style transcriptomics and DNA extraction for polygenic risk and pharmacogenomic work, alongside plasma-analyte measurement from the same draw
- Microvascular and macrovascular complications are the main clinical burden, and complication-stratified donors let you study progression rather than diagnosis alone
Donor Stratification Available
- Glycaemic control band by most recent HbA1c where available
- Treatment regimen: metformin monotherapy, GLP-1 receptor agonist, SGLT2 inhibitor, insulin-treated, or combination therapy
- Disease duration since diagnosis
- BMI and obesity status
- Presence of diabetic complications, including nephropathy, retinopathy, or neuropathy
- Comorbid hypertension, dyslipidaemia, or cardiovascular disease
- Matched healthy controls available
Product Features
- Fresh whole blood from clinically diagnosed type 2 diabetes donors
- Custom anticoagulants and collection tubes available
- Same-day collection and shipment
- Research Use Only (RUO)
- Custom volumes and multi-tube draws available on request
De-identified Donor Data
- Physician-confirmed type 2 diabetes diagnosis, including HbA1c where available
- Demographics: age, sex assigned at birth, ethnicity, BMI
- Relevant medical and medication history
- Comorbidity and complication history where recorded
Applications
- Insulin resistance and glucose metabolism studies
- HbA1c and glycaemic biomarker profiling
- Whole-blood gene expression and transcriptomic analysis
- Genomic DNA extraction for polygenic risk and pharmacogenomic studies
- Adipokine, lipid and metabolic inflammation marker measurement
- Antidiabetic drug response and mechanism-of-action research
- Diagnostic and point-of-care assay development and validation
- Complication-stratified comparisons against matched healthy controls
Other Type 2 Diabetes Specimen Types
- Type 2 Diabetes Plasma
- Type 2 Diabetes Serum
- Type 2 Diabetes PBMC
- Type 2 Diabetes Leukopak
- Type 2 Diabetes Bulk Plasma
- Type 2 Diabetes CD3+ T Cells
Compliance and Quality Assurance
- IRB-approved protocols and electronic informed consent
- HIPAA-compliant donor data handling
- Documentation support available for regulatory review
Ordering & Customization
Type 2 diabetes whole blood is available in standard and custom volumes. For pricing, availability, international orders, or documentation requirements, email learnmore@sanguinebio.com. To browse whole blood from other disease states and check live stock status, visit our human whole blood page.
Whole Blood
Frequently Asked Questions
1 Answer
YES – All collections are conducted under IRB-approved protocols and electronic informed consent. Sanguine utilizes Advarra and WCG IRB for oversight.
1 Answer
YES – all our products are research use only (RUO).
1 Answer
You can find our full product catalog here.
1 Answer
Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.
1 Answer
Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.
1 Answer
Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.
1 Answer
Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.
1 Answer
YES – we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.
1 Answer
Each sample from a different individual – Unique donor means each sample comes from a different person, ensuring biological diversity in your study.
1 Answer
YES – Unique donors can be specified and guaranteed based on your requirements.
1 Answer
For information about sample quality, please see: Quality and Compliance
1 Answer
YES – “IRB-approved collection protocols” and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.
Ask a Question
Need a custom Whole Blood cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.